Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v5-FR
Language English French
Date Updated 2021-01-16 2021-01-15
Drug Identification Number 02452987 02452987
Brand name BRIVLERA BRIVLERA
Common or Proper name BRIVLERA BRIVLERA
Company Name UCB CANADA INC UCB CANADA INC
Ingredients BRIVARACETAM BRIVARACETAM
Strength(s) 10MG 10MG
Dosage form(s) SOLUTION SOLUTION
Route of administration ORAL ORAL
Packaging size 300mL 300mL
ATC code N03AX N03AX
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2021-01-13 2021-01-13
Actual start date 2021-01-13 2021-01-13
Estimated end date 2021-01-22 2021-01-22
Actual end date 2021-01-15 2021-01-15
Shortage status Resolved Actual shortage
Company comments
Health Canada comments